GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neuland Laboratories NEULANDLAB.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

20,322.00

+3.16%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹20.23bn

FY2017FY2026

Net income

₹3.64bn

FY2017FY2026

Free cash flow

−₹588.9m

FY2017FY2026

Shareholders' equity

₹18.74bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹20.23bn₹14.34bn₹15.16bn₹11.61bn₹9.23bn₹9.18bn₹7.39bn₹6.59bn₹5.11bn₹5.66bn
Research and development—₹612.4m₹349.9m₹277.6m₹3.6m₹210.7m₹174.1m₹166.3m₹140.5m₹119.5m
Operating income₹5.07bn₹3.52bn₹4.07bn₹2.34bn₹960.9m₹1.10bn₹736.0m₹384.5m₹299.8m₹882.0m
Net income₹3.64bn₹2.60bn₹3.00bn₹1.64bn₹638.2m₹806.3m₹162.1m₹164.4m₹120.6m₹468.6m
Diluted earnings per share283.71202.74233.89127.4549.7462.8312.6412.829.4152.77

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹29.30bn₹21.80bn₹18.33bn₹15.80bn₹13.83bn₹13.25bn₹12.31bn₹11.30bn₹10.71bn₹8.86bn
Cash and short-term investments₹3.55bn₹3.67bn₹1.03bn₹454.2m₹84.7m₹105.5m₹283.1m₹314.4m₹107.9m₹109.4m
Total liabilities₹10.56bn₹6.55bn₹5.50bn₹5.86bn₹5.43bn₹5.38bn₹5.21bn₹4.31bn₹5.13bn₹3.40bn
Debt₹3.01bn₹1.57bn₹953.9m₹1.28bn₹2.41bn₹1.82bn₹2.64bn₹2.31bn₹3.19bn₹1.92bn
Shareholders' equity₹18.74bn₹15.25bn₹12.83bn₹9.94bn₹8.41bn₹7.86bn₹7.10bn₹6.99bn₹5.58bn₹5.46bn
Shares outstanding13m13m13m13m13m13m13m13m13m9m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹3.38bn₹3.17bn₹2.56bn₹2.39bn₹585.8m₹1.89bn₹573.4m₹699.1m₹112.7m₹386.8m
Capital spending−₹3.97bn−₹2.06bn−₹1.44bn−₹661.3m−₹958.8m−₹1.05bn−₹488.0m−₹631.1m−₹1.34bn−₹411.3m
Free cash flow−₹588.9m₹1.11bn₹1.12bn₹1.72bn−₹373.0m₹839.6m₹85.4m₹68.0m−₹1.22bn−₹24.5m
Dividends paid−₹154.0m−₹179.6m−₹128.3m−₹64.1m−₹38.5m−₹25.7m−₹49.5m−₹49.5m−₹49.5m−₹12.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹6.42bn₹7.76bn₹4.40bn₹5.14bn₹2.93bn₹2.86bn₹3.98bn₹3.11bn
Operating income₹1.96bn₹2.82bn₹612.7m₹1.33bn₹221.6m₹430.5m₹703.0m₹504.9m
Net income₹1.48bn₹2.13bn₹405.7m₹968.5m₹139.0m₹278.1m₹1.02bn₹328.4m
Diluted earnings per share115.10165.7631.6275.4910.8321.6779.1825.60
Cash from operations———−₹367.0m—₹3.17bn—₹1.49bn
Capital spending———−₹1.71bn—−₹2.06bn—−₹1.03bn
Free cash flow———−₹2.07bn—₹1.11bn—₹459.0m
Total assets—₹29.30bn—₹25.34bn—₹21.80bn—₹19.44bn
Cash and short-term investments₹766.7m₹3.55bn₹1.69bn₹1.80bn₹2.40bn₹3.67bn₹1.90bn₹1.90bn
Debt—₹2.02bn—₹2.65bn—₹1.57bn—₹1.09bn
Shareholders' equity₹18.74bn₹18.74bn₹16.20bn₹16.20bn₹15.25bn₹15.25bn₹13.95bn₹13.95bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue20.3%17.1%14.8%
Operating income29.3%35.8%22.8%
Net income30.6%35.2%29.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin24.8%24.5%21.4%18.3%
Net margin18.1%17.7%15.4%12.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings68.875.058.741.533.824.586.932.648.616.9
Price to sales12.413.611.65.82.32.11.90.81.11.4

Dividends and splits

Per share, in the currency the company pays

Paid for 7 years. Last went ex-dividend on 24 Jul 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year34.0012.0014.0010.005.003.002.003.20

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.